Prevalence of Hyperpigmentation Disorders in Fitzpatrick skin types

Sudeep edpuganti, Shravan Subhash, Shehna Siras, Sethulakshmi Keelathara Sajeev, Srihitha mesineni, Devaprasad Devakumar, Mohammed shahinsha

Abstract


Abstract: Hyperpigmentation is a multifactorial skin condition that mainly affects individuals with Fitzpatrick skin types III-VI.UV radiation from sunlight is the main trigger for hyperpigmentation, which is also associated with increased risk of skin cancer. Tobacco smoking and air pollution, along with several other risk factors, contribute to the development of hyperpigmentation. Despite it being very prevalent and also having a high psychosocial impact, it is an underrepresented condition in dermatological research. The main objective of this cross-sectional study is to assess the prevalence, patterns, and its psychosocial impact across individuals of different skin types. It also significantly affects the quality of life, especially in individuals with darker skin tones. Awareness of the treatment options and their affordability should be addressed to the general public. 



Keywords


Hyperpigmentation Disorders, Fitzpatrick Skin Types, Melasma, Post-Inflammatory Hyperpigmentation.

Full Text:

PDF

References


. Markiewicz E, Karaman-Jurukovska N, Mammone T, Idowu OC. Post-Inflammatory Hyperpigmentation in Dark Skin: Molecular Mechanism and Skincare Implications. Clin Cosmet Investig Dermatol.2022;15:25552565.https://doi.org/10.2147/CCID.S385162

. Thawabteh, A. M., Jibreen, A., Karaman, D., Thawabteh, A., & Karaman, R. (2023). Skin Pigmentation Types, Causes and Treatment—A Review. Molecules, 28(12), 4839. https://doi.org/10.3390/molecules28124839

. Perera, M. H., Joshi, M., Govindan, A. K., Edpuganti, S., Korrapati, N. H., & Kiladze, N. (2022). Impact of mask wear on the skin of clinical year medical students during the COVID-19 pandemic: A cross-sectional study. Cosmoderma, 2, 96. https://doi.org/10.25259/csdm_100_2022

. Rathee, P., Kumar, S., Kumar, D., Kumari, B., & Yadav, S. S. (2021). Skin hyperpigmentation and its treatment with herbs: an alternative method. Future Journal of Pharmaceutical Sciences, 7(1). https://doi.org/10.1186/s43094-021-00284-6

. Edpuganti, S., Gaikwad, J. R., Maliyil, B. T., Koshy, R. R., Potdar, R., Latheef, S., & Korrapati, N. H. (2025). The not-so-sweet side of mango: Mango allergy. Cosmoderma, 5, 18. https://doi.org/10.25259/csdm_212_2024

. Hamzavi, I., Fatima, S., Braunberger, T., Mohammad, T., & Kohli, I. (2020). The role of sunscreen in melasma and postinflammatory hyperpigmentation. Indian Journal of Dermatology, 65(1), 5. https://doi.org/10.4103/ijd.ijd_295_18

. Ashar, N. A., & Riyaningrum, W. (2022). Description of knowledge level of prevention of skin hyperpigmentation in adolescents. Proceedings Series on Health & Medical Sciences, 3, 55–61. https://doi.org/10.30595/pshms.v3i.620

. Lee, A. (2021). Skin Pigmentation Abnormalities and Their Possible Relationship with Skin Aging. International Journal of Molecular Sciences, 22(7), 3727. https://doi.org/10.3390/ijms22073727

. Divyalakshmi, C., Bhatia, R., & Hazarika, N. (2023). Do cosmetics have a role in melasma? Preliminary results of a pilot study of patch testing in melasma. Cosmoderma, 3, 99. https://doi.org/10.25259/csdm_95_2023

. García, R. M. G., & Molina, S. C. (2019). Drug-Induced Hyperpigmentation: review and case series. The Journal of the American Board of Family Medicine, 32(4), 628–638. https://doi.org/10.3122/jabfm.2019.04.180212

. Sharma, A. N., Dobry, A. S., & Linden, K. (2019). Hyperpigmentation due to cyclosporine therapy. Cureus. https://doi.org/10.7759/cureus.4072

. Goyal, P., & Chauhan, P. (2024). Maturational hyperpigmentation: An update. Cosmoderma, 4, 23. https://doi.org/10.25259/csdm_269_2023

. Jangda, A., Voloshyna, D., Ramesh, K., Bseiso, A., Shaik, T. A., Barznji, S. A., Usama, M., Saleem, F., & Ghaffari, M. a. Z. (2022). Hyperpigmentation as a primary symptom of vitamin B12 deficiency: a case report. Cureus. https://doi.org/10.7759/cureus.29008

. Amatul-Hadi, F., Cherradi, R., Khalfalla, T., Alameddine, R., Medford, A., Kooner, A., Patel, E., Farkouh, C., Do, T., Gandhi, D. N., Huynh, L., & Humayun, F. (2024). The role of Diet in Hyperpigmentation: A Systematic review examining the impact of nutrition on skin pigmentation. Clinical Dermatology and Surgery., 2(1). https://doi.org/10.61853/cds.34875

. Kandhari, S., Rao, P. N., Arsiwala, S., Ganjoo, A., Sood, S., & Kumar, D. (2021). Expert opinion on current trends in hyperpigmentation management: Indian perspective. International Journal of Research in Dermatology, 8(1), 142. https://doi.org/10.18203/issn.2455-4529.intjresdermatol20214925

. Zolghadri, S., Beygi, M., Mohammad, T. F., Alijanianzadeh, M., Pillaiyar, T., Garcia-Molina, P., Garcia-Canovas, F., Munoz-Munoz, J., & Saboury, A. A. (2023). Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises. Biochemical Pharmacology, 212, 115574. https://doi.org/10.1016/j.bcp.2023.115574

. Heidari, F., Zadeh, M. E., Zadeh, M. H. A., & Namiranian, N. (2025). The frequency of periorbital hyperpigmentation risk factors. Journal of Cosmetic Dermatology, 24(2). https://doi.org/10.1111/jocd.70036

. Nautiyal, A., & Wairkar, S. (2021). Management of hyperpigmentation: Current treatments and emerging therapies. Pigment Cell & Melanoma Research, 34(6), 1000–1014. https://doi.org/10.1111/pcmr.12986

. Wang, J. Y., Zafar, K., Bitterman, D., Patel, P., Kabakova, M., Cohen, M., & Jagdeo, J. (2025). Gender, Racial, and Fitzpatrick Skin Type Representation in Melasma Clinical Trials. Journal of drugs in dermatology : JDD, 24(1), 19–22. https://doi.org/10.36849/JDD.8379

. Bhattacharya, Ipshita; Dsouza, Paschal; Dhaka, Kanchan. Impact of postinflammatory hyperpigmentation on quality of life in patients with skin of color. Pigment International 11(1):p 33-41, January-April 2024. | DOI: 10.4103/pigmentinternational.pigmentinternational_

. Moolla, S., & Miller-Monthrope, Y. (2022). Dermatology: how to manage facial hyperpigmentation in skin of colour. Drugs in Context, 11, 1–14. https://doi.org/10.7573/dic.2021-11-2

. Fabian, I. M., Sinnathamby, E. S., Flanagan, C. J., Lindberg, A., Tynes, B., Kelkar, R. A., Varrassi, G., Ahmadzadeh, S., Shekoohi, S., & Kaye, A. D. (2023). Topical hydroquinone for hyperpigmentation: A Narrative review. Cureus. https://doi.org/10.7759/cureus.48840

. Tangau, M. J., Chong, Y. K., & Yeong, K. Y. (2022). Advances in cosmeceutical nanotechnology for hyperpigmentation treatment. Journal of Nanoparticle Research, 24(8). https://doi.org/10.1007/s11051-022-05534-z

. Rendon, M. I., & Barkovic, S. (2016). Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI. Journal of drugs in dermatology : JDD, 15(11), 1435–1441.

. Lindgren, A. L., Austin, A. H., & Welsh, K. M. (2021). The Use of Tranexamic Acid to Prevent and Treat Post-Inflammatory Hyperpigmentation. Journal of drugs in dermatology : JDD, 20(3), 344–345. https://doi.org/10.36849/JDD.5622

. Hamzavi, I., Fatima, S., Braunberger, T., Mohammad, T., & Kohli, I. (2020). The role of sunscreen in melasma and postinflammatory hyperpigmentation. Indian Journal of Dermatology, 65(1), 5. https://doi.org/10.4103/ijd.ijd_295_18

. Xing, X., Dan, Y., Xu, Z., & Xiang, L. (2022). Implications of oxidative stress in the pathogenesis and treatment of hyperpigmentation disorders. Oxidative Medicine and Cellular Longevity, 2022, 1–12. https://doi.org/10.1155/2022/7881717




DOI: http://dx.doi.org/10.52155/ijpsat.v50.1.7148

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Sudeep edpuganti, Shravan Subhash, Shehna Siras, Sethulakshmi Keelathara Sajeev, Srihitha mesineni, Devaprasad Devakumar, Mohammed shahinsha

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.